The membrane cytoskeletal component dystrophin and its associated glycoprot
eins play a central role in the molecular pathogenesis of several muscular
dystrophies, i.e. Duchenne/Becker muscular dystrophy, congenital muscular d
ystrophy and various forms of limb-girdle muscular dystrophy. Although the
most frequent of these disorders, Duchenne muscular dystrophy, is mainly re
cognized as a disease of skeletal muscle fibers, pathophysiological changes
also involve the heart and diaphragm, as well as the peripheral and centra
l nervous system. Thus current research efforts into the elucidation of the
molecular mechanisms underlying these genetic diseases are not only direct
ed towards studying skeletal muscle necrosis but also investigate abnormali
ties of heart and brain dystrophin-glycoprotein complexes in cardiomyopathy
and brain deficiencies associated with muscular dystrophy. Furthermore, ma
ny isoforms of dystrophin and dystrophin-associated components have been id
entified in various non-muscle tissues and their function(s) are mostly unk
nown. With respect to skeletal muscle fibers, the characterization of new d
ystrophin-associated proteins, such as dystrobrevin, sarcospan and the synt
rophins, led to a modified model of the spatial configuration of the dystro
phin-glycoprotein complex. However, it is generally accepted now that beta-
dystroglycan forms the plasmalemma-spanning linkage between dystrophin and
the laminin-binding protein alpha-dystroglycan and that this complex is ass
ociated with the sarcoglycan subcomplex of sarcolemmal glycoproteins.